Comments
Opto Circuits (India) on Wednesday informed the exchanges that its wholly-owned subsidiary Eurocor GmbH has received patent for bioresorbable stent, which is an alternative to the traditional vascular stent. The patent grant will bolster the extension of Eurocor’s product portfolio to include bioresorbable devices, capable of addressing significant new markets and customers globally. Shareholders of Opto Circuits will closely monitor the development.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.